Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
GlobeNewswire13d agoneutral
Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026Benzinga67d agoneutral
Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer StudyGlobeNewswire67d agoneutral
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross ProceedsGlobeNewswire83d agoneutral
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic CancerGlobeNewswire88d agoneutral
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug CandidatesMT Newswires317d agoneutral
Top Midday Stories: Nvidia-Groq Licensing Deal; Target Attracts Growing Interest From Toms Capital